Cite
Differences in HCV Seroprevalence, Clinical Features, and Treatment Outcomes between Female and Male Incarcerated Population: Results from a Matched Cohort Study.
MLA
Fiore, Vito, et al. “Differences in HCV Seroprevalence, Clinical Features, and Treatment Outcomes between Female and Male Incarcerated Population: Results from a Matched Cohort Study.” Viruses (1999-4915), vol. 15, no. 12, Dec. 2023, p. 2414. EBSCOhost, https://doi.org/10.3390/v15122414.
APA
Fiore, V., De Vito, A., Rastrelli, E., Manca, V., De Matteis, G., Ranieri, R., Pontali, E., Geremia, N., Panese, S., Starnini, G., Madeddu, G., & Babudieri, S. (2023). Differences in HCV Seroprevalence, Clinical Features, and Treatment Outcomes between Female and Male Incarcerated Population: Results from a Matched Cohort Study. Viruses (1999-4915), 15(12), 2414. https://doi.org/10.3390/v15122414
Chicago
Fiore, Vito, Andrea De Vito, Elena Rastrelli, Valentina Manca, Giuseppe De Matteis, Roberto Ranieri, Emanuele Pontali, et al. 2023. “Differences in HCV Seroprevalence, Clinical Features, and Treatment Outcomes between Female and Male Incarcerated Population: Results from a Matched Cohort Study.” Viruses (1999-4915) 15 (12): 2414. doi:10.3390/v15122414.